MedTrace Logo

Pharmacokinetics of Metformin Intolerance

NCT03361878 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-12-05

No results posted yet for this study

Summary

Pharmacokinetic study of metformin intolerance

Conditions

  • Diabetes Mellitus, Type 2
  • Metformin Adverse Reaction

Interventions

DRUG

Metformin Hydrochloride

Single dose of 500mg oral metformin

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • University of Dundee

    collaborator OTHER

  • Helmholtz Zentrum München

    collaborator INDUSTRY

  • NHS Tayside

    lead OTHER_GOV

Principal Investigators

  • Laura McCreight, MBChB · University of Dundee

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-04
Primary Completion
2016-05-05
Completion
2016-05-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03361878 on ClinicalTrials.gov